This exploratory opinion, requested by the Danish Presidency, outlines how AI and Big Data can improve rare disease patient pathways and support the development of personalised treatments. It highlights the main challenges linked to their use, such as data privacy, algorithmic bias, affordability, and geographical accessibility. In the text, the EESC puts forward recommendations to ensure that these technologies are applied in an ethical, inclusive, and patient-centred way.
The EESC welcomes the overall positive trade balance of the EU and calls for measures to maintain it, while recommending targeted support for strategically important industries, stronger investment conditions, and effective financing through the Single Market, the Savings and Investments Union, and a more integrated capital market. The EESC also underlines the need to support ambitious companies entering global markets, ensure opportunities for highly skilled professionals, simplify procedures without undermining social and environmental standards, create fiscal space for growth-enhancing investments, and strengthen multilateralism through new trade agreements and WTO reforms.
